Trends in substance abuse preceding stroke among young adults: a population-based study
- PMID: 23160887
- PMCID: PMC3742309
- DOI: 10.1161/STROKEAHA.112.667808
Trends in substance abuse preceding stroke among young adults: a population-based study
Abstract
Background and purpose: Approximately 5% of strokes occur in adults aged 18 to 44 years. Substance abuse is a prevalent risk factor for stroke in young adults. We sought to identify trends in substance abuse detection among stroke patients.
Methods: Using a population-based design, we sought to identify all patients aged 18 to 54 years experiencing a stroke (ischemic or hemorrhagic) in the Greater Cincinnati and Northern Kentucky Study region during 1993 to 1994, 1999, and 2005. Demographic and clinical characteristics and substance use data were obtained retrospectively from chart review and adjudicated by physicians.
Results: The number of young patients identified with a stroke increased from 1993 to 1994 (297) to 2005 (501). Blacks (61% vs 51%; P<0.02) and men (61% vs 47%; P<0.002) reported substance abuse (current smoking, alcohol, or illegal drug use) more frequently than did whites and women. Overall use of substances increased across study periods, 45% in 1993 versus 62% in 2005 (P=0.003). The trend was significant for illegal drug use (3.8% in 1993 vs 19.8% in 2005) and ever smoking (49% in 1993 vs 66% in 2005). Documentation of both cocaine and marijuana use increased over time. In 2005, half of young adults with a stroke were current smokers, and 1 in 5 abused illegal drugs.
Conclusions: Substance abuse is common in young adults experiencing a stroke. The observed increase in substance abuse is contributing to the increased incidence of stroke in young adults. Patients aged younger than 55 years who experience a stroke should be routinely screened and counseled regarding substance abuse.
Conflict of interest statement
Dr. Kissela receives research support from the NIH and honoraria from Allergan and Reata pharmaceuticals.
Dr. Kleindorfer receives research support from the NIH and the CDC. She is a member of the speaker's bureau, Genentech, and has served as a legal expert.
Dr. Khatri receives research support from the NIH as well as research and travel support as an unpaid consultant from Genentech, also receives research support from Penumbra as PI of THERAPY Trial. She is consultant/advisor for Jannsen Pharmaceuticals and has served as a legal expert.
The remaining authors report no conflicts of interests.
References
-
- Ellis C. Stroke in young adults. Disability and Health Journal. 2010;3:222–224. - PubMed
-
- Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: A population-based study of hospitalized patients. ArchGenPsychiatry. 2007;64:495. - PubMed
-
- Kittner SJ, Stern BJ, Wozniak M, Buchholz DW, Earley CJ, Feeser BR, et al. Cerebral infarction in young adults - the baltimore-washington cooperative young stroke study. Neurology. 1998;50:890–894. - PubMed
-
- Toossi S, Hess CP, Hills NK, Josephson SA. Neurovascular complications of cocaine use at a tertiary stroke center. Journal of Stroke and Cerebrovascular Diseases. 2010;19:273. - PubMed
